Company · CIK 0001658247 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Crinetics Pharmaceuticals, Inc. · CRNX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 DForm 4 → | Sep 1, 5:02 pm EDT | Wendell WierengaDirector | 122,071 | $85.00 | $10,376,035 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:02 pm EDT | Coelho Rogerio VivaldiDirector | 19,225 | $85.00 | $1,634,125 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Stephanie OkeyDirector | 12,325 | $85.00 | $1,047,625 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Weston NicholsDirector | 22,225 | $85.00 | $1,889,125 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Matthew K FustDirector | 28,761 | $85.00 | $2,444,685 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:00 pm EDT | Caren DeardorfDirector | 22,225 | $85.00 | $1,889,125 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:00 pm EDT | Camille L BedrosianDirector | 22,225 | $85.00 | $1,889,125 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:55 pm EDT | Isabel KalofonosChief Commercial Officer | 35,669 | $85.00 | $3,031,865 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:54 pm EDT | Stephen F. BetzChief Scientific Officer | 137,936 | $85.00 | $11,724,560 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:53 pm EDT | Tobin SchilkeChief Financial & Infra. Ofcr. | 79,427 | $85.00 | $6,751,295 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:52 pm EDT | Richard Scott StruthersPresident & CEO, Director | 1,402,911 | $85.00 | $119,247,435 | 0 | — | |
| Aug 20, 2026 AForm 4 → | Aug 24, 4:52 pm EDT | Tobin SchilkeChief Financial & Infra. Ofcr. | 471 | — | — | 79,427 | — | |
| Aug 7, 2026 MForm 4 → | Aug 11, 4:11 pm EDT | Richard Scott StruthersPresident & CEO, Director | 19,928 | $20.07 | $399,988 | 424,706 | — | |
| Jul 2, 2026 SForm 4 → | Jul 7, 4:30 pm EDT | Coelho Rogerio VivaldiDirector | 3,000 | $40.00 | $120,000 | 19,225 | −13.5% | 10b5-1 |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:09 pm EDT | Caren DeardorfDirector | 5,925 | — | — | 22,225 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:05 pm EDT | Matthew K FustDirector | 5,925 | — | — | 28,761 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:04 pm EDT | Weston NicholsDirector | 5,925 | — | — | 22,225 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:03 pm EDT | Coelho Rogerio VivaldiDirector | 5,925 | — | — | 22,225 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:02 pm EDT | Camille L BedrosianDirector | 5,925 | — | — | 22,225 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:01 pm EDT | Wendell WierengaDirector | 5,925 | — | — | 122,071 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:00 pm EDT | Stephanie OkeyDirector | 5,925 | — | — | 12,325 | — | |
| Jun 17, 2026 SForm 4 → | Jun 18, 5:23 pm EDT | Stephanie OkeyDirector | 6,900 | $35.67 | $246,143 | 6,400 | −51.9% | 10b5-1 |
| Feb 20, 2019 JForm 4 → | Feb 22, 8:06 pm EST | 5AM Ventures IV, L.P. +510% Owner | 484,569 | — | — | 1,723 | — | plan? |
| Feb 4, 2019 JForm 4 → | Feb 6, 5:35 pm EST | Versant Venture Capital V, L.P. +510% Owner | 527,890 | — | — | 0 | — | plan? |
| Jan 22, 2019 SForm 4 → | Jan 24, 7:01 pm EST | 5AM Ventures IV, L.P. +510% Owner | 262,153 | $21.88 | $5,734,597 | 129,483 | −66.9% | plan? |
| Nov 20, 2018 JForm 5 → | Feb 12, 2019, 5:29 pm EST | Marc WilsonSee Remarks | 1,470 | $14.45 | $21,242 | 57,321 | — | plan? |
| Nov 20, 2018 JForm 5 → | Feb 12, 2019, 5:25 pm EST | Alan Seth KrasnerChief Medical Officer | 1,470 | $14.45 | $21,242 | 3,470 | — | plan? |
| Jul 20, 2018 CForm 4/A → | Aug 27, 6:12 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 1,880,305 | — | — | 2,187,953 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 20, 7:02 pm EDT | 5AM Ventures IV, L.P. +510% Owner | 115,000 | $17.00 | $1,955,000 | 139,969 | +461% | plan? |
| Jul 20, 2018 CForm 4 → | Jul 20, 7:02 pm EDT | 5AM Ventures IV, L.P. +510% Owner | 3,384,278 | — | — | 135,369 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 20, 5:19 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 400,000 | $17.00 | $6,800,000 | 2,280,305 | +21.3% | plan? |
| Jul 20, 2018 CForm 4 → | Jul 20, 5:19 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 1,880,305 | — | — | 1,880,305 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 20, 4:50 pm EDT | Vivo Capital VIII, LLC +510% Owner | 353,180 | $18.62 | $6,575,421 | 294,357 | — | plan? |
| Jul 20, 2018 CForm 4 → | Jul 20, 4:50 pm EDT | Vivo Capital VIII, LLC +510% Owner | 3,384,278 | — | — | 410,625 | — | plan? |
| Jul 20, 2018 CForm 4 → | Jul 20, 4:34 pm EDT | Versant Venture Capital V, L.P. +310% Owner | 3,384,276 | — | — | 226,025 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 20, 4:06 pm EDT | Alan Seth KrasnerChief Medical Officer | 2,000 | $17.00 | $34,000 | 2,000 | — | plan? |
| Jul 18, 2018 PForm 4/A → | Aug 27, 6:12 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 707,648 | $18.87 | $13,352,902 | 2,587,953 | +37.6% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 DForm 4 → | Sep 1, 5:02 pm EDT | Wendell WierengaDirector | 110,080 | $59.08 | $6,503,719 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:02 pm EDT | Coelho Rogerio VivaldiDirector | 93,830 | $55.70 | $5,226,557 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Stephanie OkeyDirector | 105,080 | $57.91 | $6,085,544 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Weston NicholsDirector | 110,080 | $59.08 | $6,503,719 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:01 pm EDT | Matthew K FustDirector | 52,172 | $54.29 | $2,832,519 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:00 pm EDT | Caren DeardorfDirector | 89,455 | $58.69 | $5,250,051 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 5:00 pm EDT | Camille L BedrosianDirector | 110,080 | $60.71 | $6,682,594 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:55 pm EDT | Isabel KalofonosChief Commercial Officer | 152,500 | $43.26 | $6,596,525 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:54 pm EDT | Stephen F. BetzChief Scientific Officer | 767,304 | $62.55 | $47,993,850 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:53 pm EDT | Tobin SchilkeChief Financial & Infra. Ofcr. | 130,000 | $47.39 | $6,160,500 | 0 | — | |
| Sep 1, 2026 DForm 4 → | Sep 1, 4:52 pm EDT | Richard Scott StruthersPresident & CEO, Director | 1,939,822 | $56.53 | $109,658,984 | 0 | — | |
| Aug 7, 2026 MForm 4 → | Aug 11, 4:11 pm EDT | Richard Scott StruthersPresident & CEO, Director | 19,928 | — | — | 244,205 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:09 pm EDT | Caren DeardorfDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:05 pm EDT | Matthew K FustDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:04 pm EDT | Weston NicholsDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:03 pm EDT | Coelho Rogerio VivaldiDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:02 pm EDT | Camille L BedrosianDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:01 pm EDT | Wendell WierengaDirector | 9,730 | — | — | 9,730 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 5:00 pm EDT | Stephanie OkeyDirector | 9,730 | — | — | 9,730 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:44 pm EDT | Richard Scott StruthersPresident & CEO, Director | 176,250 | — | — | 176,250 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:43 pm EDT | Marc WilsonChief Financial Officer | 56,250 | — | — | 56,250 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:42 pm EDT | Alan Seth KrasnerChief Medical Officer | 56,250 | — | — | 56,250 | — | |
| Jul 20, 2018 CForm 4/A → | Aug 27, 6:12 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 6,186,205 | — | — | 0 | — | |
| Jul 20, 2018 CForm 4 → | Jul 20, 7:02 pm EDT | 5AM Ventures IV, L.P. +510% Owner | 11,134,278 | — | — | 0 | — | |
| Jul 20, 2018 CForm 4 → | Jul 20, 5:19 pm EDT | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 6,186,205 | — | — | 0 | — | |
| Jul 20, 2018 CForm 4 → | Jul 20, 4:50 pm EDT | Vivo Capital VIII, LLC +510% Owner | 11,134,278 | — | — | 0 | — | |
| Jul 20, 2018 CForm 4 → | Jul 20, 4:34 pm EDT | Versant Venture Capital V, L.P. +310% Owner | 11,134,276 | — | — | 0 | — |